en

PRODUCT DETAIL

Bilastine Polpharma

Code 0744F
MA number 24/0246/25-S
Product Form: tbl 100x20 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Zaklady Farmaceutyczne POLPHARMA S.A., Poland
Therapeutic Class: 24 - ANTIHISTAMINICA, HISTAMIN
ATC:
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX29 Bilastine
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 30.07.2025
Validity: 30.07.2030
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Bilastine Polpharma_OTC_07.2025.pdf  
PIL: PIL_Bilastine Polpharma_Rx_07.2025.pdf  
SPC: SPC_Bilastine Polpharma_07.2025.pdf  
Safety feature Yes
Data update: 01.08.2025
eu-flag.png sk-flag.png